Dr. Alpdogan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 S 11th St
Philadelphia, PA 19107Phone+1 215-955-6000Fax+1 215-955-8549
Summary
- Dr. S. Onder Alpdogan is an oncologist in Philadelphia, PA and is affiliated with Thomas Jefferson University Hospitals. He received his medical degree from Hacettepe University Faculty of Medicine and has been in practice 33 years. He also speaks multiple languages, including Turkish. He specializes in hematologic oncology and is experienced in immunotherapy, bone marrow transplantation, B-cell lymphomas, T-cell lymphomas, and Hodgkin Lymphoma.
Clinical Expertise
- Hematologic Cancers, Bone marrow transplantation, Immunotherapy, T-cell lymphomas, Lymphoma, B-cell lymphomas, Hodgkin's lymphoma, Medical oncology, Ophthalmic oncology, Pediatric hematology / oncology, Complex medical dermatology
Education & Training
- Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2006 - 2009
- Memorial Sloan Kettering Cancer CenterFellowship, Transplant Immunology, 2000 - 2003
- Marmara University HospitalFellowship, Hematology, 1992 - 1995
- Hacettepe University FOMClass of 1983
Certifications & Licensure
- NJ State Medical License 2019 - 2025
- PA State Medical License 2009 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2011-2013
Publications & Presentations
PubMed
- 1 citationsPhase I/II study of bendamustine in combination with ofatumumab, carboplatin, etoposide (BOCE) for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma.Jonathan Pan, Sushil Ghimire, S. Onder Alpdogan, Andrew E. Chapman, Matthew Carabasi
Leukemia & Lymphoma. 2021-02-23 - 58 citationsClostridium difficile colonization and disease in patients undergoing hematopoietic stem cell transplantationJackrapong Bruminhent, Zi-Xuan Wang, Carol Hu, John L. Wagner, Richard Sunday
Biology of Blood and Marrow Transplantation. 2014-09-01 - 14 citationsNew interleukin-15 superagonist (IL-15SA) significantly enhances graft-versus-tumor activityCavan P. Bailey, Tulin Budak-Alpdogan, Christopher Sauter, Michelle M. Panis, Cihangir Buyukgoz
Oncotarget. 2017-05-15
Authored Content
- SOHO 2021: Advances in Peripheral T Cell Lymphoma (PTCL) TreatmentSeptember 2021
Professional Memberships
- Member
- Member
- American Society Blood and Marrow TransplantationMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: